Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111696644 | 11169664 | 4 | F | 20140522 | 20160613 | 20150605 | 20160712 | EXP | PHHY2015TW040142 | NOVARTIS | 75.84 | YR | M | Y | 0.00000 | 20160712 | MD | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111696644 | 11169664 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 OT, UNK | 22068 | CAPSULE | |||||||||
| 111696644 | 11169664 | 2 | C | FERROUS GLUCONATE | FERROUS GLUCONATE | 1 | Oral | 1 DF, UNK | Y | 0 | 1 | DF | TABLET | ||||||
| 111696644 | 11169664 | 3 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 10 MG, UNK | Y | 0 | 10 | MG | |||||||
| 111696644 | 11169664 | 4 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0.5 MG, UNK | Y | 0 | .5 | MG | |||||||
| 111696644 | 11169664 | 5 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0.5 MG, UNK | Y | 0 | .5 | MG | |||||||
| 111696644 | 11169664 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK | 0 | ||||||||||
| 111696644 | 11169664 | 7 | C | SULPIRIDE | SULPIRIDE | 1 | Oral | 50 MG, UNK | Y | 0 | 50 | MG | |||||||
| 111696644 | 11169664 | 8 | C | DIMETHICONE. | DIMETHICONE | 1 | Oral | 40 MG, UNK | Y | 0 | 40 | MG | |||||||
| 111696644 | 11169664 | 9 | C | DICYCLOVERINE | 2 | Oral | 10 MG, UNK | Y | 0 | 10 | MG | ||||||||
| 111696644 | 11169664 | 10 | C | DICLOFENAC | DICLOFENAC | 1 | Intramuscular | 40 MG, UNK | Y | 0 | 40 | MG | |||||||
| 111696644 | 11169664 | 11 | C | CO TRAMADOL/ACET | 2 | Oral | 1 DF, UNK | Y | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111696644 | 11169664 | 1 | Chronic myeloid leukaemia |
| 111696644 | 11169664 | 2 | Iron deficiency anaemia |
| 111696644 | 11169664 | 3 | Insomnia |
| 111696644 | 11169664 | 4 | Insomnia |
| 111696644 | 11169664 | 6 | Hypertension |
| 111696644 | 11169664 | 7 | Product used for unknown indication |
| 111696644 | 11169664 | 8 | Product used for unknown indication |
| 111696644 | 11169664 | 9 | Product used for unknown indication |
| 111696644 | 11169664 | 10 | Product used for unknown indication |
| 111696644 | 11169664 | 11 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111696644 | 11169664 | Dry skin | |
| 111696644 | 11169664 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111696644 | 11169664 | 1 | 20130515 | 0 | ||
| 111696644 | 11169664 | 2 | 20130508 | 20130911 | 0 | |
| 111696644 | 11169664 | 3 | 20130508 | 20130814 | 0 | |
| 111696644 | 11169664 | 4 | 20140102 | 0 | ||
| 111696644 | 11169664 | 5 | 20140227 | 20140813 | 0 | |
| 111696644 | 11169664 | 6 | 20140619 | 0 | ||
| 111696644 | 11169664 | 7 | 20131119 | 20131122 | 0 | |
| 111696644 | 11169664 | 8 | 20131119 | 20131122 | 0 | |
| 111696644 | 11169664 | 9 | 20131119 | 20131122 | 0 | |
| 111696644 | 11169664 | 10 | 20131119 | 20131122 | 0 | |
| 111696644 | 11169664 | 11 | 20130619 | 20130703 | 0 |